Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank60
3Y CAGR+60.9%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+60.9%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
4.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.21M | -28.2% |
| 2024 | $8.64M | +26.2% |
| 2023 | $6.85M | +359.7% |
| 2022 | $1.49M | +2625.4% |
| 2021 | $-59000.00 | +97.2% |
| 2020 | $-2.14M | - |